Details

---

Manufacturer
Immacule Lifesciences Private Limited(INDIA)

Registraction Number
MAL24076020AZ

Content:

• Active Ingredient: Esomeprazole Sodium (equivalent to 40 mg Esomeprazole)

Indication:
ESCOPRO is indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. It is also used for the prevention of gastric ulcers associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs).
Instructions:

1. Dosage: The typical dose for adults is 40 mg once daily. For patients with Zollinger-Ellison syndrome, the initial dose may be higher.
2. Administration: The powder should be reconstituted with 100 mL of 5% glucose solution or 0.9% saline. The reconstituted solution should be administered via intravenous infusion over 20-30 minutes.
3. Monitoring: Patients should be monitored for adverse reactions and effectiveness of the treatment.
4. Precautions: Use with caution in patients with impaired hepatic function. Dose adjustments may be necessary.